Do cordyceps, reishi and chaga supplements have human evidence?

Some do, but the human evidence is limited. Cordyceps, reishi and lion's mane each have a few small or early human trials, usually with stated gram-level doses, and chaga is mostly described through its compounds and lab-style pharmacology. A supplement that lists these mushrooms with no amounts cannot be matched against any of that research.

"Medicinal mushroom" supplements are popular for brain, energy, immune and heart claims. This guide looks at what the studies I could open actually tested, how much people took, and what that means when you read a blend label.

What do medicinal mushroom studies look like overall?

A 2023 systematic review of mushroom supplements in cancer care opens with a blunt line: patients ask about mushroom supplements, but most research on such fungi has been preclinical, meaning lab and animal work. It screened 2,349 papers and found 39 clinical studies that met its criteria, covering 12 different mushroom preparations. It also noted that many of those studies were small and observational, and concluded the evidence was inconclusive for routine use. That review is about cancer care, not the brain or energy products we audit, but the pattern it describes is common across this whole category: plenty of lab data, fewer human trials, and small ones.

Does cordyceps have human evidence?

There is some, mostly on exercise. A double-blind, placebo-controlled pilot trial gave 20 healthy adults aged 50 to 75 either a cordyceps product called Cs-4 or placebo, 333 mg three times a day for 12 weeks, which is about 1,000 mg a day. The metabolic threshold rose 10.5 percent in the Cs-4 group, and there was no change in VO2 max in either group. The authors called it a pilot study.

That is a real human result with a stated dose, which is more than many sales pages offer. It also shows the limits: 20 people, one product, one outcome, and no change in the headline fitness measure. It does not tell you what a capsule that lists cordyceps among nine other ingredients would do.

Our reviews show what happens when a formula includes cordyceps without an amount. Mindoxa puts six mushrooms into one proprietary blend with no stated amounts. Longevity Activator does print a number for its cordyceps, 25 to 50 mg, which our review says is on the low end of what is typically studied.

Does reishi have human evidence?

Reishi (Ganoderma lucidum) has been tested, and the results for heart and blood sugar markers are not encouraging. A Cochrane review of reishi for cardiovascular risk factors found five trials with 398 participants. The three trials that had usable data compared 1.4 g to 3 g a day with placebo over 12 to 16 weeks, and all participants had type 2 diabetes. Two studies showed no statistically or clinically significant reduction in HbA1c, total cholesterol or LDL cholesterol. The reviewers concluded that evidence from a small number of trials does not support using reishi for these risk factors in people with type 2 diabetes.

The doses matter here too. The trials used grams a day. The Cholibrium review describes a heart formula with ten mushrooms, a 365-day refund and no amount stated for any of them, plus a reference list that includes sources about unrelated topics. Our review notes that human cholesterol evidence for reishi is weaker than the page implies.

The Cochrane authors also said risk of bias was low in only one of the five studies. Small trials with unclear methods are a recurring theme.

What about chaga?

Chaga (Inonotus obliquus) is the hardest of the three to pin down. A 2024 review covering chaga and two other medicinal mushrooms describes its bioactive compounds, such as polysaccharides, triterpenoids and phenolic compounds, and points to pharmacological studies. Its abstract gives no dose that you could compare with a capsule label. In our Cholibrium review, chaga is described as having antioxidant and immune research with limited direct human data for the heart claim being made.

Chaga also appears inside undisclosed blends. NervoLink prints a stated 266 mg for four mushrooms (cordyceps, reishi, shiitake and lion's mane) but puts chaga and five others in a blend with no individual amounts. Our review found no study connecting these mushrooms to peripheral nerve health in people.

Is lion's mane the best-supported mushroom?

It is the one most often cited by memory formulas, and it has a small trial behind it. In a Japanese double-blind trial, 30 people aged 50 to 80 with mild cognitive impairment were split into two groups of 15. The mushroom group took four 250 mg tablets of 96 percent lion's mane powder, three times a day, for 16 weeks. That is 3 grams a day. Scores on a cognitive scale were higher than placebo at weeks 8, 12 and 16, then dropped significantly four weeks after they stopped.

Fifteen people per group is small, and the trial studied people with a diagnosed condition, not healthy people looking for sharper focus. It still gives a concrete number to compare against. Vitrafoxin cites this kind of research and our review credits its reference list for being on topic, but the product states no milligram amount for any of its four mushrooms, so the dose cannot be compared with 3 grams. For NervoLink, the label states 266 mg of lion's mane, against 3 g a day in that trial.

What does a mushroom blend label hide?

Product	Mushroom amounts on the label	Key point from our review
Mindoxa	None stated	Six mushrooms in one blend; 180-day refund
Vitrafoxin	None stated	On-topic references, no doses; 365-day refund
NervoLink	266 mg each for four, none for the rest	Reference list mostly unrelated to nerves
Cholibrium	None stated for ten mushrooms	Reference list includes unrelated sources
TonicGreens	None stated	57-plus ingredients, mushrooms in an immune blend

Mushroom potency also varies by preparation. A fruiting body powder, a mycelium grown on grain and a concentrated extract are different materials, and a dose from one trial does not transfer to another product. Our TonicGreens review notes that mushroom extract potency varies enormously by preparation, which that page never describes.

How can you evaluate a mushroom supplement?

1. Look for the part of the mushroom (fruiting body, mycelium or extract) and a milligram amount for each species.
2. Compare that amount with a trial of the same species and form. The trials above used about 1 g, 1.4 to 3 g and 3 g a day.
3. Ask what the trial measured. Exercise threshold, HbA1c and a cognition scale are different outcomes and none proves a claim about nerves, energy or immunity.
4. Open the reference list. If studies are about sleep, obesity or a laxative herb, the page is borrowing credibility.
5. Check the refund window and process in our ClickBank refund guide, and see how we weigh these points in how we review. You can also browse the brain and memory category.

FAQ about cordyceps, reishi and chaga

Is there proof that reishi lowers cholesterol?

A Cochrane review of five small trials did not find a statistically or clinically significant effect on total or LDL cholesterol in people with type 2 diabetes. That is a finding about those trials and those people, not about every mushroom product.

How much cordyceps was used in human studies?

The pilot trial I opened used 333 mg of Cs-4 three times a day for 12 weeks in 20 healthy older adults. Other products and other studies may differ.

Do mushroom supplements have side effects?

The Cochrane reishi review reported that participants who took reishi for four months were more likely to have an adverse event than those on placebo, though not serious ones, and the difference was not conclusive. If you take medicine or have a medical condition, ask your doctor or pharmacist before starting any mushroom product.

Can a mushroom blend replace treatment for memory problems?

No. Memory changes should be checked by a doctor. The lion's mane trial above studied people with a diagnosed condition under study conditions, and its authors reported scores falling after the mushroom was stopped.